levodopa has been researched along with Learning Disabilities in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 6 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Graybiel, AM; Hernandez, LF; Howe, MW; Hu, D; Kubota, Y; Lemaire, N | 1 |
| Apud, JA; Bigelow, LB; Das, S; Egan, MF; Goldberg, TE; Mattay, VS; Weickert, TW; Weinberger, DR | 1 |
| Fuhrer, H; Gruber, D; Hälbig, TD; Kopp, UA; Kupsch, A; Scherer, P | 1 |
| Bohnen, NI; Kwak, Y; Schonfeld, D; Seidler, R; Vaillancourt, DE | 1 |
| Miklya, I | 1 |
| Broussolle, E; Mollion, H; Thobois, S; Ventre-Dominey, J | 1 |
| Danysz, W; Dekundy, A; Gravius, A; Morè, L; Nagel, J; Pietraszek, M | 1 |
| Geghman, KD; Gluck, MA; Myers, CE; Sage, J; Shohamy, D | 1 |
| Ambrée, O; de Souza Silva, MA; Dere, E; Herring, A; Keyvani, K; Lewejohann, L; Paulus, W; Richter, H; Sachser, N; Schäbitz, WR | 1 |
| Polkey, CE; Robbins, TW; Rogers, RD; Sahakian, BJ; Summers, BA; Swainson, R | 1 |
1 review(s) available for levodopa and Learning Disabilities
| Article | Year |
|---|---|
Dopamine overdose hypothesis: evidence and clinical implications.
Topics: Brain; Cognition Disorders; Dopamine; Dopamine Agents; Humans; Learning Disabilities; Levodopa; Parkinson Disease | 2013 |
1 trial(s) available for levodopa and Learning Disabilities
| Article | Year |
|---|---|
Probabilistic learning and reversal deficits in patients with Parkinson's disease or frontal or temporal lobe lesions: possible adverse effects of dopaminergic medication.
Topics: Adult; Antiparkinson Agents; Discrimination, Psychological; Epilepsy; Female; Frontal Lobe; Humans; Learning Disabilities; Levodopa; Male; Models, Statistical; Neostriatum; Parkinson Disease; Pattern Recognition, Visual; Reversal Learning; Space Perception; Temporal Lobe; Visual Perception | 2000 |
8 other study(ies) available for levodopa and Learning Disabilities
| Article | Year |
|---|---|
Selective effects of dopamine depletion and L-DOPA therapy on learning-related firing dynamics of striatal neurons.
Topics: Action Potentials; Analysis of Variance; Animals; Animals, Newborn; Conditioning, Operant; Corpus Striatum; Disease Models, Animal; Dopamine; Dopamine Agents; Electric Stimulation; Electrochemical Techniques; Learning Disabilities; Levodopa; Male; Maze Learning; Neural Pathways; Neurotoxins; Oxidopamine; Rats; Rats, Sprague-Dawley; Reaction Time; Time Factors | 2013 |
Dopaminergic therapy removal differentially effects learning in schizophrenia and Parkinson's disease.
Topics: Adult; Aged; Association Learning; Dopamine Agents; Female; Humans; Learning Disabilities; Levodopa; Male; Middle Aged; Parkinson Disease; Psychiatric Status Rating Scales; Schizophrenia; Young Adult | 2013 |
Levodopa inhibits habit-learning in Parkinson’s disease.
Topics: Adult; Aged; Antiparkinson Agents; Association Learning; Choice Behavior; Cues; Ecosystem; Female; Humans; Learning Disabilities; Levodopa; Male; Middle Aged; Parkinson Disease | 2014 |
Essential difference between the pharmacological spectrum of (-)-deprenyl and rasagiline.
Topics: Animals; Indans; Learning Disabilities; Levodopa; Male; Neurons; Parkinson Disease; Rats; Rats, Wistar; Selegiline; Tetrabenazine | 2014 |
Distinct effects of dopamine vs STN stimulation therapies in associative learning and retention in Parkinson disease.
Topics: Adult; Aged; Association Learning; Deep Brain Stimulation; Disability Evaluation; Dopamine; Dopamine Agents; Female; Humans; Learning Disabilities; Levodopa; Male; Maze Learning; Middle Aged; Neuropsychological Tests; Parkinson Disease; Photic Stimulation; Reaction Time; Retention, Psychology; Subthalamic Nucleus; Time Factors | 2016 |
Investigation on tolerance development to subchronic blockade of mGluR5 in models of learning, anxiety, and levodopa-induced dyskinesia in rats.
Topics: Animals; Antiparkinson Agents; Anxiety Disorders; Brain; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Tolerance; Dyskinesia, Drug-Induced; Excitatory Amino Acid Antagonists; Glutamic Acid; Learning Disabilities; Levodopa; Male; Maze Learning; Memory Disorders; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Synaptic Transmission; Thiazoles | 2008 |
L-dopa impairs learning, but spares generalization, in Parkinson's disease.
Topics: Aged; Analysis of Variance; Antiparkinson Agents; Case-Control Studies; Discrimination, Psychological; Female; Generalization, Psychological; Humans; Learning; Learning Disabilities; Levodopa; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease | 2006 |
Levodopa ameliorates learning and memory deficits in a murine model of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Analysis of Variance; Animals; Corpus Striatum; Disease Models, Animal; Dopamine; Dopamine Agents; Frontal Lobe; Hippocampus; Learning Disabilities; Levodopa; Male; Maze Learning; Memory Disorders; Mice; Mice, Transgenic; Nootropic Agents; Recognition, Psychology | 2009 |